Your browser doesn't support javascript.
loading
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lindsay, Holly B; Massimino, Maura; Avula, Shivaram; Stivaros, Stavros; Grundy, Richard; Metrock, Katie; Bhatia, Aashim; Fernández-Teijeiro, Ana; Chiapparini, Luisa; Bennett, Jeffrey; Wright, Karen; Hoffman, Lindsey M; Smith, Amy; Pajtler, Kristian W; Poussaint, Tina Young; Warren, Katherine E; Foreman, Nicholas K; Mirsky, David M.
Affiliation
  • Lindsay HB; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: hblindsa@texaschildrens.org.
  • Massimino M; Department of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumouri, Milan, Italy.
  • Avula S; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Stivaros S; Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Division of Informatics, Imaging, and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
  • Grundy R; Children's Brain Tumour Research Centre, The Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
  • Metrock K; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Bhatia A; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Fernández-Teijeiro A; Pediatric Onco-Hematology Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Chiapparini L; Neuroradiology Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Bennett J; Radiology Ltd, Tucson, AZ, USA.
  • Wright K; Department of Pediatric Oncology, Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Hoffman LM; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Smith A; Orlando Health-Arnold Palmer Hospital, Orlando, FL, USA.
  • Pajtler KW; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany; Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Poussaint TY; Department of Radiology, Boston Children's Hospital, Boston, MA, USA.
  • Warren KE; Department of Pediatric Oncology, Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Foreman NK; The Morgan Adams Foundation Pediatric Brain Tumour Research Program, Department of Pediatrics, Center for Cancer and Blood Disorders, Children's Hospital Colorado, CO, USA.
  • Mirsky DM; Department of Radiology, Children's Hospital Colorado, CO, USA.
Lancet Oncol ; 23(8): e393-e401, 2022 08.
Article in En | MEDLINE | ID: mdl-35901835
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Central Nervous System Neoplasms / Ependymoma Type of study: Guideline / Prognostic_studies Limits: Adult / Child / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Central Nervous System Neoplasms / Ependymoma Type of study: Guideline / Prognostic_studies Limits: Adult / Child / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: